Reduced Health-Related Quality of Life in Body Constitutions of Yin-Xu, and Yang-Xu, Stasis in Patients with Type 2 Diabetes: Taichung Diabetic Body Constitution Study
Table 1
Comparisons of basic characteristics between constitutions of Yin-Xu, Yang-Xu, and Stasis.
Variable
Total
Yin-Xu
Yang-Xu
Stasis
No
Yes
value
No
Yes
value
No
Yes
value
Gender
Male, (%)
405 (57.5%)
304 (43.1%)
101 (14.3%)
0.05
369 (52.3%)
36 (5.11%)
0.00**
364 (51.6%)
41 (5.82%)
0.01*
Age (yr)
63.90 ± 13.35
63.24 ± 13.24
65.61 ± 13.53
0.04*
63.97 ± 13.21
63.45 ± 14.36
0.72
63.79 ± 13.29
64.69 ± 13.81
0.58
BMI (kg/m2)
25.46 ± 4.01
25.46 ± 4.15
25.46 ± 3.63
0.97
25.43 ± 3.99
25.67 ± 4.13
0.59
25.32 ± 3.98
26.45 ± 4.05
0.01*
Duration of diabetes (years)
9.03 ± 8.12
8.74 ± 7.69
9.78 ± 9.14
0.15
8.86 ± 7.81
10.16 ± 9.95
0.21
9.05 ± 8.04
8.87 ± 8.72
0.78
Waist (cm)
89.10 ± 10.65
89.33 ± 10.88
88.52 ± 10.02
0.40
89.17 ± 10.48
88.63 ± 11.76
0.66
88.67 ± 10.44
92.07 ± 11.56
0.01*
Smoking
0.87
0.88
0.13
No
691 (98.01%)
499 (70.78%)
192 (27.23%)
602 (85.39%)
89 (12.62%)
605 (85.82%)
86 (12.20%)
Sometimes
9 (1.28%)
6 (0.85%)
3 (0.43%)
8 (1.13%)
1 (0.14%)
7 (0.99%)
2 (0.28%)
Usually
5 (0.71%)
4 (0.57%)
1 (0.14%)
4 (0.57%)
1 (0.14%)
3 (0.43%)
2 (0.28%)
Physical activity
0.09
0.02*
0.004**
No
149 (21.19%)
98 (13.94%)
51 (7.25%)
123 (17.50%)
26 (3.70%)
118 (16.79%)
31 (4.41%)
Sometimes
197 (28.02%)
138 (19.63%)
59 (8.39%)
164 (23.33%)
33 (4.69%)
170 (24.18%)
27 (3.84%)
Usually
357 (50.79%)
271 (38.55%)
86 (12.23%)
325 (46.23%)
32 (4.55%)
325 (46.23%)
32 (4.55%)
GFR (mL/min)
67.37 ± 22.11
68.73 ± 21.44
63.91 ± 23.43
0.03*
67.62 ± 21.12
65.75 ± 27.85
0.38
67.52 ± 21.38
66.35 ± 26.78
0.82
Microalbumin (mg/dL)
21.96 ± 69.64
19.42 ± 59.95
28.40 ± 89.47
0.19
20.86 ± 67.13
29.84 ± 87.44
0.41
20.81 ± 66.62
30.05 ± 87.98
0.34
Fasting glucose (mg/dL)
142.98 ± 48.20
142.34 ± 44.75
144.62 ± 56.17
0.51
141.82 ± 45.28
150.73 ± 64.15
0.18
142.14 ± 47.84
148.73 ± 50.54
0.15
HbA1c (%)
7.65 ± 1.58
7.59 ± 1.52
7.80 ± 1.71
0.11
7.61 ± 1.56
7.92 ± 1.70
0.08
7.58 ± 1.56
8.10 ± 1.66
0.004**
Triglycerides (mg/dL)
151.99 ± 170.80
154.82 ± 195.41
144.80 ± 79.36
0.36
151.28 ± 177.51
156.68 ± 117.94
0.73
155.89 ± 177.56
152.66 ± 115.79
0.99
HDL-C (mg/dL)
52.02 ± 14.10
52.31 ± 14.44
51.26 ± 13.20
0.61
52.14 ± 14.24
51.18 ± 13.18
0.53
52.13 ± 14.16
51.20 ± 13.71
0.85
LDL-C (mg/dL)
106.26 ± 31.33
105.39 ± 30.23
108.52 ± 34.04
0.39
105.90 ± 31.43
108.76 ± 30.75
0.31
105.26 ± 30.73
113.58 ± 34.79
0.04*
SBP (mmHg)
131.35 ± 14.67
131.38 ± 14.56
131.30 ± 14.97
0.98
131.50 ± 14.37
130.38 ± 16.61
0.49
131.24 ± 14.52
132.13 ± 15.74
0.54
DBP (mmHg)
77.53 ± 9.21
77.67 ± 9.06
77.18 ± 9.59
0.56
77.43 ± 9.02
78.24 ± 10.43
0.47
77.62 ± 9.11
76.90 ± 9.87
0.55
Data were presented as mean ± SD; , . BMI: body mass index; GPT: glutamic pyruvic transaminase; GFR: glomerular filtration rate; HbA1c: glycosylated hemoglobin; HDL: high density lipoprotein; LDL: low density lipoprotein; SBP: systolic blood pressure; DBP: diastolic blood pressure.
